First, in a cohort of 52 primary ccRCC samples, using RT-qPCR and immunohistochemistry, we showed that miR-21 overexpression was correlated with PPAR-α downregulation. The gene discussed is PPARA; the disease is nonpapillary renal cell carcinoma.